Finance

Lists
Why is RHY down 7,89%?
Dive Deeper
RHY:ASX
Rhythm Biosciences Ltd
0,070 A$
-7,89%
(-0,0060) 1D
13 қаз., 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RHY...
Open
0,07 A$
High
0,07 A$
Low
0,07 A$
Mkt. cap
23,22 млн
Avg. vol.
212,36 м.
Volume
304,51 м.
52-wk high
0,28 A$
52-wk low
0,07 A$
EPS
-0,02 A$
Shares outstanding
364,06 млн
Open
0,07 A$
High
0,07 A$
Low
0,07 A$
Mkt. cap
23,22 млн
Avg. vol.
212,36 м.
Volume
304,51 м.
52-wk high
0,28 A$
52-wk low
0,07 A$
EPS
-0,02 A$
Shares outstanding
364,06 млн
News stories
From web sources and news partners
About Rhythm Biosciences Ltd
CEOTrevor Lockett
Employees-
Founded2017
Headquarters-
SectorHealth care provider
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
811,07 м.
811,07 м.
59,29 мың
59,29 мың
Cost of goods sold
385,44 м.
385,44 м.
-179,08 м.
-179,08 м.
Cost of revenue
385,44 м.
385,44 м.
-179,08 м.
-179,08 м.
Research and development expenses
-
-
519,97 м.
519,97 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,49 млн
1,49 млн
1,49 млн
1,49 млн
Operating expense
1,53 млн
1,53 млн
2,06 млн
2,06 млн
Total operating expenses
1,92 млн
1,92 млн
1,88 млн
1,88 млн
Operating income
-1,11 млн
-1,11 млн
-1,82 млн
-1,82 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,13 млн
-1,13 млн
-1,84 млн
-1,84 млн
EBT excluding unusual items
-1,13 млн
-1,13 млн
-1,84 млн
-1,84 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,13 млн
-1,13 млн
-1,84 млн
-1,84 млн
Net profit margin
-139,15%
-139,15%
-3 097,39%
-3 097,39%
Earnings per share
-
-
-
-
Interest and investment income
15,09 мың
15,09 мың
-
-
Interest expense
-34,76 мың
-34,76 мың
-17,73 мың
-17,73 мың
Net interest expenses
-19,67 мың
-19,67 мың
-17,73 мың
-17,73 мың
Depreciation and amortization charges
40,42 мың
40,42 мың
45,23 мың
45,23 мың
EBITDA
-1,06 млн
-1,06 млн
-1,77 млн
-1,77 млн
Gain or loss from assets sale
-
-
-1,52 мың
-1,52 мың
AI content may include mistakes. Learn more
Google қолданбалары